文献速递眼底病与葡萄膜炎

脉络膜上腔曲安奈德治疗难治性术后囊样黄斑水肿

SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE FOR REFRACTORY POSTOPERATIVE CYSTOID MACULAR EDEMA.
PubMed 文献 · Retina · 2024-01-01

回顾性研究纳入32例难治性术后囊样黄斑水肿患者(32眼),接受脉络膜上腔曲安奈德注射,随访中位6个月。中央凹厚度从基线492 µm降至1个月267 µm(P<0.001)、3个月362 µm(P=0.005)、末次随访339 µm(P<0.001);最佳矫正视力中位logMAR从基线0.65改善至末次0.60(P=0.021)。6眼(18.8%)出现眼压升高(>24 mmHg),均有青光眼或高眼压史。

要点

  • 脉络膜上腔曲安奈德可降低难治性术后囊样黄斑水肿的中央凹厚度并改善视力。
  • 玻璃体切除眼也观察到相似效果。
  • 6眼(18.8%)出现眼压升高(>24 mmHg),均有青光眼或高眼压史。

核心结论

  • 脉络膜上腔曲安奈德减轻难治性术后囊样黄斑水肿的黄斑水肿并改善视力,包括玻璃体切除眼。
  • 应监测眼压,尤其是有青光眼或高眼压史者。

研究设计与样本

  • 回顾性病历回顾,纳入32例患者32眼,接受脉络膜上腔曲安奈德(XIPERE,Bausch + Lomb)治疗难治性术后囊样黄斑水肿。
  • 中位(四分位距)随访6(2-7)个月,中位(四分位距)注射1(1-2)次;19眼(59.4%)有玻璃体切除史。
  • 主要结局为视力和中央凹厚度。

主要发现

  • 中央凹厚度中位(四分位距)从基线492(379-629)µm降至1个月267(187-388)µm(P<0.001)、3个月362(218-521)µm(P=0.005)、末次随访339(206-514)µm(P<0.001)。
  • logMAR视力中位(四分位距)从基线0.65(0.48-0.97,20/89)改善至1个月0.54(0.35-0.88,20/69)(P=0.058)、3个月0.54(0.33-0.84,20/69)(P=0.121)、末次随访0.60(0.33-0.88,20/80)(P=0.021)。
  • 玻璃体切除眼有相似发现。
  • 6眼(18.8%)出现眼压升高(>24 mmHg)(范围25-49 mmHg),眼压较基线中位升高13.5 mmHg,均有青光眼或高眼压史。

临床怎么用

  • 作者结论认为脉络膜上腔曲安奈德可减轻难治性术后囊样黄斑水肿并改善视力,包括玻璃体切除眼。
  • 作者结论认为应监测眼压,尤其是有青光眼或高眼压史者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate outcomes of suprachoroidal triamcinolone acetonide (XIPERE, Bausch + Lomb) for the treatment of refractory postoperative cystoid macular edema. METHODS: Medical records of patients receiving suprachoroidal triamcinolone acetonide for postoperative cystoid macular edema were reviewed. Primary outcomes were visual acuity and central foveal thickness. RESULTS: A total of 32 eyes from 32 patients with a median (interquartile range) follow-up duration of 6 (2-7) months and 1 (1-2) suprachoroidal triamcinolone acetonide injection were included; 19 (59.4%) had a history of vitrectomy. The median (interquartile range) central foveal thickness decreased from 492 (379-629) µm to 267 (187-388) µm at 1 month (P < 0.001), 362 (218-521) µm at 3 months (P = 0.005), and 339 (206-514) µm at the final visit (P < 0.001). The median logarithm of the minimal angle of resolution visual acuity improved from 0.65 (0.48-0.97, 20/89) at baseline to 0.54 (0.35-0.88, 20/69) (P = 0.058) at 1 month, 0.54 (0.33-0.84, 20/69) at 3 months (P = 0.121), and 0.60 (0.33-0.88, 20/80) at the final visit (P = 0.021). Vitrectomized eyes had similar findings. Six eyes (18.8%) developed elevated intraocular pressure (>24 mmHg) (range: 25-49 mmHg) with a median intraocular pressure elevation of 13.5 mmHg compared with baseline, and all had prior glaucoma or ocular hypertension. CONCLUSION: Suprachoroidal triamcinolone acetonide reduced macular edema and improved vision in refractory postoperative cystoid macular edema, including vitrectomized eyes. Intraocular pressure should be monitored, especially in those with a history of glaucoma or ocular hypertension.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Momenaei B, Pandit SA, Wang KY, et al. SUPRACHOROIDAL TRIAMCINOLONE ACETONIDE FOR REFRACTORY POSTOPERATIVE CYSTOID MACULAR EDEMA. Retina. 2024. PMID: 39047129. doi:10.1097/IAE.0000000000004132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。